ºÐÀÚÇ¥ÀûÄ¡·á(MTT) ½ÃÀåÁ¶»çº¸°í¼­

ºÐÀÚÇ¥ÀûÄ¡·á(MTT) ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå±Ô¸ð, »ê¾÷ºÐ¼®, ÇâÈÄ ½ÃÀå¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 231°Ç)
¼¼°èÀÇ Ç×ü Ä¡·áÁ¦ ½ÃÀå
Antibody Therapeutics
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,496,000 (ºÎ°¡¼¼ º°µµ)
µ¿¹° ÀÇ·á¿ë ´ÜŬ·ÐÇ×ü ½ÃÀå ºÐ¼®°ú ¿¹Ãø : À¯Çü, Á¦Ç°, ¼­ºñ½º, ±â¼ú, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, ÇÁ·Î¼¼½º, ±â´É(-2034³â)
Monoclonal Antibodies In Veterinary Health Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Process, Functionality
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,750 £Ü 6,898,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾Ï Ç×ü¾à¹°Á¢ÇÕü(ADC) ½ÃÀå
Cancer Antibody Drug Conjugates
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,496,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ç×CD38 ´ÜÀÏŬ·ÐÇ×ü ½ÃÀå : ½ÃÀå ±Ô¸ð, ´ë»ó ȯÀÚ, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2034³â)
Anti-CD38 mAb Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 7,950 £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ALK Ç¥Àû Ä¡·áÁ¦ ½ÃÀå : ´ë»ó ȯÀÚ Áý´Ü, °æÀï ±¸µµ, ¿¹Ãø(-2034³â)
Anaplastic Lymphoma Kinase (ALK) Targeted Therapies - Target Population, Competitive Landscape, and Market Forecast - 2034
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 7,950 £Ü 11,546,000 (ºÎ°¡¼¼ º°µµ)
¿ïÅä¹Ì¸®½º¾à ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Ultomiris Drug Market Size, Share & Trends Analysis Report By Indication (PNH, Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder), By End Use, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,950 £Ü 8,641,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ç×ü Ž»ö ½ÃÀå
Antibody Discovery
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,496,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Å°³ª¾ÆÁ¦ ½Å¾à °³¹ß ¼Ö·ç¼Ç ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Kinase Drug Discovery Solutions Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 3,850 £Ü 5,591,000 (ºÎ°¡¼¼ º°µµ)
Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå : ºÐÇØ ÀåÄ¡ À¯Çüº°, ÀûÀÀÁõº°, ÁÖ¿ä Áö¿ªº°
Targeted Protein Degradation Market Distribution by Type of Degrader, Target Indication, Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World )
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,799 £Ü 6,970,000 (ºÎ°¡¼¼ º°µµ)
ÆÛÁ¦Å¸(Perjeta) ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ÀûÀÀÁõº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Perjeta Market Size, Share & Trends Analysis Report By Product (Monoclonal Antibody, Generic Drug), By Indication (Early Breast Cancer), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,950 £Ü 8,641,000 (ºÎ°¡¼¼ º°µµ)
·¹¹ÌÄÉÀÌµå ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : À¯Çüº°, ÀûÀÀÁõº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Remicade Market Size, Share & Trends Analysis Report By Type (Branded, Biosimilar), By Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,950 £Ü 8,641,000 (ºÎ°¡¼¼ º°µµ)
ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀå : Á¦Ç° À¯Çüº°, ±â¼úº°, ¿ëµµº°, Áö¿ªº°
Molecular Cytogenetics Market, By Product Type, By Technology, By Application, By Geography
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,500 £Ü 6,535,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ÙÁ߯¯À̼º Ç×ü ½ÃÀå : ¾à¹° ¸ÅÃâ, ¿ë·®, °¡°Ý, ÀÓ»ó½ÃÇè µ¿Çâ(2030³â)
Global Multispecific Antibodies Market, Drug Sales, Dosage, Price & Clinical Trials Insight 2030
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 6,000 £Ü 8,714,000 (ºÎ°¡¼¼ º°µµ)
Ç×ü °øµ¿ ¿¬±¸ ¹× ¶óÀ̼±½Ì °è¾à(2019-2025³â)
Antibody Collaboration and Licensing Deals 2019-2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 3,995 £Ü 5,802,000 (ºÎ°¡¼¼ º°µµ)
¾Ï ´ÜŬ·ÐÇ×ü °øµ¿ ¿¬±¸ ¹× ¶óÀ̼±½Ì °è¾à(2016-2025³â)
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 3,995 £Ü 5,802,000 (ºÎ°¡¼¼ º°µµ)
´ÜŬ·ÐÇ×ü °øµ¿ ¿¬±¸ ¹× ¶óÀ̼±½Ì °è¾à(2019-2025³â)
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 3,995 £Ü 5,802,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Æ¿µå¶óŰÁÖ¸¿(Tildrakizumab) ½ÃÀå º¸°í¼­(2025³â)
Tildrakizumab Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,521,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ CD20 Ç×ü ½ÃÀå º¸°í¼­(2025³â)
CD20 Antibody Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,521,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ CD-19 Ç×ü ½ÃÀå º¸°í¼­(2025³â)
CD-19 Antibody Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,521,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾ÐŸ¸Ó ½ÃÀå : À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2026-2032³â)
Aptamers Market By Type (RNA-Based, DNA-Based), Application (Therapeutics, Diagnostics), End-Users (Academic and Government Research Institutes, Contract Research Organizations), & Region for 2026-2032
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,950 £Ü 5,736,000 (ºÎ°¡¼¼ º°µµ)
ÀϺ»ÀÇ Ç×ü Ä¡·áÁ¦ ½ÃÀå : Á¦Ç° À¯Çüº°, ÀûÀÀ Áúȯº°, Åõ¿© °æ·Îº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, ±âȸ, ¿¹Ãø(2019-2033³â)
Japan Antibody Therapeutics Market Assessment, By Product Type, By Disease Indication, By Route of Administration, By End-user, By Region, Opportunities and Forecast, FY2019-FY2033F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,500 £Ü 5,083,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ º£¹Ù½ÃÁÖ¸¿(Bevacizumab) - ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀλçÀÌÆ®(2025³â)
Bevacizumab - Biosimilar Insight, 2025
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 2,000 £Ü 2,904,000 (ºÎ°¡¼¼ º°µµ)
ÀÌÁ߯¯À̼ºÇ×ü ½ÃÀå : ÀÛ¿ë±âÀü, Ä¡·á ºÐ¾ß, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Bispecific Antibodies Market by Mechanism of Action, Therapeutic Area, End-user - Global Forecast 2025-2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,939 £Ü 5,721,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ç×ü Ä¡·áÁ¦ ½ÃÀå : Æ÷¸Ë, Åõ¿© °æ·Î, °ø±Þ¿ø, Áúȯ ¿µ¿ª, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¿¹Ãø(2025-2030³â)
Antibody Therapeutics Market by Format, Route of Administration, Source, Disease Areas, Application, End-User - Global Forecast 2025-2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,939 £Ü 5,721,000 (ºÎ°¡¼¼ º°µµ)
Ç×ü »ý»ê ½ÃÀå : Á¦Ç° À¯Çü, »ý»ê °øÁ¤, Ŭ·¡½º, Á¤Á¦ ¹æ¹ý, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Antibody Production Market by Product, Antibody Type, Production Process, Class, Purification Method, Application, End-User - Global Forecast 2025-2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,939 £Ü 5,721,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.